SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Arcus Biosciences initiated as Buy by TD Cowen

Benzinga reports TD Cowen initiated coverage on Arcus Biosciences with a Buy rating.

RCUS

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories